Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Keefer

Showing results (1021-1030 of 1,129) with videos related to

Pageof 113
Sort By:
AIDS (London, England)|January 6, 1999
Induction of immune responses to HIV-1 by canarypox virus (ALVAC) HIV-1 and gp120 SF-2 recombinant vaccines in uninfected volunteers. NIAID AIDS Vaccine Evaluation GroupR B Belshe, G J Gorse, M J Mulligan, et al.
The Journal of Infectious Diseases|August 6, 2004
Breakthrough infections during phase 1 and 2 prime-boost HIV-1 vaccine trials with canarypox vectors (ALVAC) and booster dose of recombinant gp120 or gp160Deborah Lee, Barney S Graham, Ya-Lin Chiu, et al.
Frontiers in Immunology|November 8, 2021
CD4+ T Cells Are Dispensable for Induction of Broad Heterologous HIV Neutralizing Antibodies in Rhesus MacaquesSanghita Sarkar, David A Spencer, Philip Barnette, et al.
JAMIA Open|May 5, 2023
A machine learning approach to determine resilience utilizing wearable device data: analysis of an observational cohortRobert P Hirten, Maria Suprun, Matteo Danieletto, et al.
AIDS Research and Human Retroviruses|October 6, 1997
Safety profile of phase I and II preventive HIV type 1 envelope vaccination: experience of the NIAID AIDS Vaccine Evaluation GroupM C Keefer, M Wolff, G J Gorse, et al.
Plos One|July 6, 2016
Humoral Dysregulation Associated with Increased Systemic Inflammation among Injection Heroin UsersMichael S Piepenbrink, Memorie Samuel, Bo Zheng, et al.
The Journal of Infectious Diseases|March 20, 2004
Comparison of systemic and mucosal delivery of 2 canarypox virus vaccines expressing either HIV-1 genes or the gene for rabies virus G proteinPeter F Wright, Jiri Mestecky, M Juliana McElrath, et al.
The Journal of Infectious Diseases|September 9, 1999
Immunization with envelope MN rgp120 vaccine in human immunodeficiency virus-infected pregnant womenP F Wright, J S Lambert, G J Gorse, et al.
Journal of Virology|October 23, 2009
Differential specificity and immunogenicity of adenovirus type 5 neutralizing antibodies elicited by natural infection or immunizationCheng Cheng, Jason G D Gall, Martha Nason, et al.
Scientific Reports|August 5, 2020
Impact of vaccine type on HIV-1 vaccine elicited antibody durability and B cell gene signatureRohith Palli, Kelly E Seaton, Michael S Piepenbrink, et al.
Pageof 113

Showing results (1021-1030 of 1,129) with videos related to

Sort By:
Pageof 113
AIDS (London, England)|January 6, 1999
Induction of immune responses to HIV-1 by canarypox virus (ALVAC) HIV-1 and gp120 SF-2 recombinant vaccines in uninfected volunteers. NIAID AIDS Vaccine Evaluation GroupR B Belshe, G J Gorse, M J Mulligan, et al.
The Journal of Infectious Diseases|August 6, 2004
Breakthrough infections during phase 1 and 2 prime-boost HIV-1 vaccine trials with canarypox vectors (ALVAC) and booster dose of recombinant gp120 or gp160Deborah Lee, Barney S Graham, Ya-Lin Chiu, et al.
Frontiers in Immunology|November 8, 2021
CD4+ T Cells Are Dispensable for Induction of Broad Heterologous HIV Neutralizing Antibodies in Rhesus MacaquesSanghita Sarkar, David A Spencer, Philip Barnette, et al.
JAMIA Open|May 5, 2023
A machine learning approach to determine resilience utilizing wearable device data: analysis of an observational cohortRobert P Hirten, Maria Suprun, Matteo Danieletto, et al.
AIDS Research and Human Retroviruses|October 6, 1997
Safety profile of phase I and II preventive HIV type 1 envelope vaccination: experience of the NIAID AIDS Vaccine Evaluation GroupM C Keefer, M Wolff, G J Gorse, et al.
Plos One|July 6, 2016
Humoral Dysregulation Associated with Increased Systemic Inflammation among Injection Heroin UsersMichael S Piepenbrink, Memorie Samuel, Bo Zheng, et al.
The Journal of Infectious Diseases|March 20, 2004
Comparison of systemic and mucosal delivery of 2 canarypox virus vaccines expressing either HIV-1 genes or the gene for rabies virus G proteinPeter F Wright, Jiri Mestecky, M Juliana McElrath, et al.
The Journal of Infectious Diseases|September 9, 1999
Immunization with envelope MN rgp120 vaccine in human immunodeficiency virus-infected pregnant womenP F Wright, J S Lambert, G J Gorse, et al.
Journal of Virology|October 23, 2009
Differential specificity and immunogenicity of adenovirus type 5 neutralizing antibodies elicited by natural infection or immunizationCheng Cheng, Jason G D Gall, Martha Nason, et al.
Scientific Reports|August 5, 2020
Impact of vaccine type on HIV-1 vaccine elicited antibody durability and B cell gene signatureRohith Palli, Kelly E Seaton, Michael S Piepenbrink, et al.
Pageof 113